109 related articles for article (PubMed ID: 19237840)
21. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
Holtmann G; Layer P; Goebell H
Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357
[TBL] [Abstract][Full Text] [Related]
22. A prospective evaluation of the effect of chronic proton pump inhibitor use on plasma biomarker levels in humans.
Raines D; Chester M; Diebold AE; Mamikunian P; Anthony CT; Mamikunian G; Woltering EA
Pancreas; 2012 May; 41(4):508-11. PubMed ID: 22460728
[TBL] [Abstract][Full Text] [Related]
23. The effect of cimetidine on serum acidic markers and Helicobacter pylori in gastric ulcer subjects.
Lee CT; Chang FY; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jan; 57(1):28-33. PubMed ID: 8820033
[TBL] [Abstract][Full Text] [Related]
24. Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough.
Mainie I; Tutuian R; Castell DO
J Clin Gastroenterol; 2008 Jul; 42(6):676-9. PubMed ID: 18496394
[TBL] [Abstract][Full Text] [Related]
25. Heartburn, gastroesophageal reflux (GER), and gastroesophageal reflux disease (GERD).
J Pract Nurs; 2008; 58(3):21-3. PubMed ID: 19180847
[No Abstract] [Full Text] [Related]
26. Plasma gastrin measurement cannot be used to diagnose a gastrinoma in patients on either proton pump inhibitors or histamine type-2 receptor antagonists.
Dhillo WS; Jayasena CN; Lewis CJ; Martin NM; Tang KC; Meeran K; Todd JF
Ann Clin Biochem; 2006 Mar; 43(Pt 2):153-5. PubMed ID: 16536918
[TBL] [Abstract][Full Text] [Related]
27. [Indications for anti-ulcer drugs in adults].
Chassany O
Presse Med; 2000 Jan; 29(2):94-7. PubMed ID: 10682038
[No Abstract] [Full Text] [Related]
28. [Gastroduodenal ulcer--changes in surgical therapy by long-term drug treatment].
Peitsch W
Zentralbl Chir; 1986; 111(23):1433-40. PubMed ID: 2881413
[TBL] [Abstract][Full Text] [Related]
29. Gastric neuroendocrine carcinoma after long-term use of proton pump inhibitor.
Jianu CS; Lange OJ; Viset T; Qvigstad G; Martinsen TC; Fougner R; Kleveland PM; Fossmark R; Hauso Ø; Waldum HL
Scand J Gastroenterol; 2012 Jan; 47(1):64-7. PubMed ID: 22087794
[TBL] [Abstract][Full Text] [Related]
30. Serum pancreastatin: the long sought universal, sensitive, specific tumor marker for neuroendocrine tumors?
Ito T; Igarashi H; Jensen RT
Pancreas; 2012 May; 41(4):505-7. PubMed ID: 22504376
[No Abstract] [Full Text] [Related]
31. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness analysis: stress ulcer bleeding prophylaxis with proton pump inhibitors, H2 receptor antagonists.
Barkun AN; Adam V; Martel M; Bardou M
Value Health; 2013; 16(1):14-22. PubMed ID: 23337211
[TBL] [Abstract][Full Text] [Related]
33. [Effect of H2-receptor antagonist and proton pomp inhibitor on the treatment of acid-related disease].
Kawai T; Yagi K; Moriyasu F
Nihon Rinsho; 2015 Jul; 73(7):1159-62. PubMed ID: 26165073
[TBL] [Abstract][Full Text] [Related]
34. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
35. Gastric Acid Suppression-More Data, Less Answers.
Tofil NM; Prabhakaran P
Pediatr Crit Care Med; 2015 Sep; 16(7):671-2. PubMed ID: 26335114
[No Abstract] [Full Text] [Related]
36. Uses and abuses of acid-suppression therapy in children.
Hassall E
J Pediatr Gastroenterol Nutr; 2011 Dec; 53 Suppl 2():S8-9. PubMed ID: 22235449
[No Abstract] [Full Text] [Related]
37. Acid suppression and ulcer healing: dichotomy, degree, and dilemma.
Hunt RH
Am J Gastroenterol; 1988 Sep; 83(9):964-6. PubMed ID: 2901221
[No Abstract] [Full Text] [Related]
38. Differences in utilisation of gastroprotective drugs between 2001 and 2005 in Australia and Nova Scotia, Canada.
Tett SE; Sketris I; Cooke C; van Zanten SV; Barozzi N
Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):735-43. PubMed ID: 23559528
[TBL] [Abstract][Full Text] [Related]
39. [Antagonists of the histamine H2 receptors in the stomach].
Landa L
Gac Med Mex; 1981 Dec; 117(12):472-4. PubMed ID: 6123460
[No Abstract] [Full Text] [Related]
40. Overuse of Acid-Suppression Therapy at an Urban Tertiary Hospital.
Redfern RE; Brown M; Karhoff KL; Middleton JL
South Med J; 2015 Dec; 108(12):732-8. PubMed ID: 26630894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
